Impedimed Limited (IPD) Stock Statistics & Valuation Metrics

Impedimed Limited has a market cap or net worth of AU$18.31M. The enterprise value is AU$12.52.

Impedimed Limited has 3,662,493,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Impedimed Limited’s return on equity (ROE) is -2.44 and return on invested capital (ROIC) is -73.32%.

The current PE Ratio of Impedimed Limited is ―. Impedimed Limited’s PEG ratio is -0.25.

In the last 12 months, Impedimed Limited had revenue of 14.61M and earned -24.91M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -20.03M and capital expenditures 20.03M, giving a free cash flow of 0.00 billion.

Impedimed Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Impedimed Limited upcoming earnings date is Oct 29, 2026, TBA (Confirmed).

Impedimed Limited as a current ratio of 3.81, with Debt / Equity ratio of 162.91%

In the past 12 months, Impedimed Limited has paid -1.18M in taxes.

Impedimed Limited EV to EBITDA ratio is -0.54, with an EV/FCF ratio of -0.60.

Impedimed Limited has AU$15.29M in cash and marketable securities with AU$16.60M in debt, giving a net cash position of -AU$1.31M billion.

Gross margin is -81.36%, with operating margin of -151.27%, and net profit margin of -170.44%.

The average price target for Impedimed Limited is AU$0.01, which is 11.43% higher than the current price. The consensus rating is Moderate Buy